Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6VUE

wild-type choline TMA lyase in complex with 1-methyl-1,2,3,6-tetrahydropyridin-3-ol

6VUE の概要
エントリーDOI10.2210/pdb6vue/pdb
分子名称Choline trimethylamine-lyase, SODIUM ION, (3S)-1-methyl-1,2,3,6-tetrahydropyridin-3-ol, ... (4 entities in total)
機能のキーワードcholine-tma lyase, microbiome choline cutc inhibitor, lyase, lyase-inhibitor complex, lyase/inhibitor
由来する生物種Desulfovibrio alaskensis (strain G20)
タンパク質・核酸の鎖数2
化学式量合計183444.55
構造登録者
Ortega, M.A.,Drennan, C.L. (登録日: 2020-02-15, 公開日: 2020-11-04, 最終更新日: 2023-10-11)
主引用文献Bollenbach, M.,Ortega, M.,Orman, M.,Drennan, C.L.,Balskus, E.P.
Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.
Acs Med.Chem.Lett., 11:1980-1985, 2020
Cited by
PubMed Abstract: The anaerobic conversion of choline to trimethylamine (TMA) by the human gut microbiota has been linked to multiple human diseases. The potential impact of this microbial metabolic activity on host health has inspired multiple efforts to identify small molecule inhibitors. Here, we use information about the structure and mechanism of the bacterial enzyme choline TMA-lyase (CutC) to develop a cyclic choline analog that inhibits the conversion of choline to TMA in bacterial whole cells and in a complex gut microbial community. biochemical assays and a crystal structure suggest that this analog is a competitive, mechanism-based inhibitor. This work demonstrates the utility of structure-based design to access inhibitors of radical enzymes from the human gut microbiota.
PubMed: 33062182
DOI: 10.1021/acsmedchemlett.0c00005
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.28 Å)
構造検証レポート
検証レポート(詳細版)ダウンロードをダウンロード

237735

件を2025-06-18に公開中

PDB statisticsPDBj update infoContact PDBjnumon